Dr. Murray currently oversees the clinical research enterprise of Meharry Medical School in conjunction Metro Nashville General Hospital, and directs the Participant and Clinical Interactions Resources Center (formerly CRC) funded by the NIH/NCRR/NIMHD RCTR grant. He has been PI of several other key functions/activities of the Meharry RCTR including the Regulatory and Educational/training key activities, and also serves as a co-investigator of the Meharry-Vanderbilt CTSA. He was the PI of a successful NIH/NCRR P20 CTSA Planning grant that served as the basis of the partnership of Meharry with the Vanderbilt CTSA and the Meharry RCTR. Dr. Murray is a member of the Vanderbilt Executive Committee for the Clinical Investigator training programs and was co-PI of an NIH/NCRR/NIMHD grant entitled “Clinical Research Education for Career Development” (CRECD) that served to maintain a graduate level program at Meharry Medical College training physicians in clinical research and awards a Masters of Science in Clinical Investigation degree. Currently, he remains as director of this program in the School of Graduate Studies and Research and continues to mentor residents, students and young faculty in clinical and translational research.
Dr. Murray has been a faculty member of academic medical centers throughout his entire career, and has overseen numerous clinical studies (e.g., NIH funded, investigator initiated) on several Clinical Research Centers. Given his background in clinical and translational medicine, he serves at Meharry as Associate Vice President for Research and had been the Institutional Officer for the IRB. He was the Meharry PI of the NHLBI U01 Asthma Disparities grant, and now serves as the PI on an NIH NHLBI P30 funded grant to establish a cardiovascular center. Dr. Murray has been involved with over 100 clinical trials leading to the establishment of a funded endowed chair for clinical research at Vanderbilt. His clinical research has now broadened across all therapeutics areas including acute coronary syndrome, hypertension and diabetes in his role of director of the PCIR. In his role as director of the PCIR, Dr. Murray has added the oversight recently of the Cancer Clinical Trials Office at Nashville General Hospital at Meharry. Dr. Murray has served as a reviewer and on study sections of both NIH and foundations, and a long time associate editor of Lipids. He continues to be an active clinical investigator on numerous clinical research projects while maintaining an active clinical immunology specialty practice acknowledged by his peers for many years as one of the “Best Doctors in America.”